epristeride has been researched along with Carcinoma, Transitional Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, CK; Chan, LW; Chan, SF; Chan, SY; Cheng, CW; Cheung, HY; Lai, FM; Li, ML; Ng, CF; To, KF; Wong, WS | 1 |
1 trial(s) available for epristeride and Carcinoma, Transitional Cell
Article | Year |
---|---|
Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.
Topics: 5-alpha Reductase Inhibitors; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Androstadienes; BCG Vaccine; Carcinoma, Transitional Cell; Cross-Over Studies; Cystectomy; Cystoscopy; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms | 2005 |